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Oxidants and iron in chronic kidney disease. Oxidants derived
either from leukocytes in proliferative glomerular nephritis or
from resident glomerular cells in nonproliferative glomeru-
lonephritis have been shown to have several biologic effects rel-
evant to chronic kidney disease. These include: the ability of ox-
idants to damage glomerular basement membrane (GBM) and
to directly induce proteinuria; effects that would lead to a fall
in the glomerular filtration rate; and effects that would account
for the morphologic changes observed in chronic kidney disease.
In experimental models the role of oxidants has been demon-
strated in both proliferative glomerulonephritis (e.g., anti-GBM
antibody disease) as well as experimental models of minimal
change disease and membranous nephropathy. Oxidants have
also been shown to be an important mediator of the various
pathways that have been implicated in diabetic nephropathy.
Antioxidants and iron chelators have also been shown to retard
functional and morphologic changes observed in progressive
kidney disease. Taken together, these experimental studies sug-
gest an important role of oxidants in chronic kidney disease.
I will introduce the term “oxidants” and present the ev-
idence available in support of the role of oxidants and iron
in chronic kidney disease. The biologic effects of oxidants
relevant to chronic kidney disease and their role in exper-
imental glomerular disease [1–4], diabetic nephropathy
[5–8], and progression of kidney disease [9, 10] will be
reviewed.
Oxygen normally accepts four electrons and is con-
verted directly to water. However, partial reduction of
oxygen can and does occur in biologic systems, leading
to the generation of partially reduced and potentially
toxic reactive oxygen. Thus, sequential reduction of oxy-
gen along the univalent pathway leads to the generation
of superoxide anion, hydrogen peroxide, hydroxyl rad-
ical, and water. Superoxide and hydrogen peroxide ap-
pear to be the primary species generated (Fig. 1). These
may then play a role in the generation of additional and
more reactive oxidants, including the highly reactive hy-
droxyl radical (or a related highly oxidizing species). Iron
salts play a catalytic role in a reaction commonly referred
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to as the metal-catalyzed Haber-Weiss (Fenton) reaction
[11]. Additional oxidants may be formed as a result of the
metabolism of hydrogen peroxide by neutrophil-derived
myeloperoxidase (MPO), the enzyme responsible for
the green color of pus, to produce highly reactive toxic
products, including hypochlorous acid (HOCl, the active
ingredient in household bleach). These oxygen metabo-
lites, including the free radical species superoxide and
hydroxyl radical, and other metabolites, such as hydro-
gen peroxide and hypohalous acids, are often collectively
referred to as reactive oxygen metabolites (ROM), or
oxidants.
BIOLOGIC EFFECTS OF OXIDANTS RELEVANT
TO CHRONIC KIDNEY DISEASE
I have divided the biologic effects of oxidants into
those that are most relevant to the three major manifesta-
tions of glomerular disease [2, 4]: occurrence of protein-
uria, altered glomerular filtration rate, and morphologic
changes. These effects are relevant both to various pro-
liferative and nonproliferative glomerulonephritides and
diabetic nephropathy.
Proteinuria
It is generally accepted that leukocytes cause protein-
uria (a hallmark of glomerular diseases) by damaging the
glomerular basement membrane (GBM) that serves as
the major ultrafiltration barrier to restrict the entry of
proteins into the urinary space. The degradation of the
GBM by stimulated neutrophils was shown to be due
to the activation of a latent metalloenzyme (most likely
gelatinase) by hypochlorous acid, or a similar oxidant
generated by the myeloperoxidase-hydrogen peroxide-
halide system (Table 1).
Oxidants may also contribute to glomerular base-
ment membrane damage by increasing its susceptibil-
ity to proteolytic damage and by inactivating the alpha-
1–proteinase inhibitor (the primary regulator of neu-
trophil elastase), thus allowing the released elastase to
more readily inflict damage to the extracellular matrix.
Oxidants also impair the synthesis of glomerular hep-
aran sulfate proteoglycans, which are needed to maintain
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Fig. 1. Formation of oxidants.
integrity of the glomerular basement membrane and nor-
mal glomerular ultrafiltration.
Several direct in vivo studies indicate that oxidants are
capable of inducing glomerular injury, resulting in pro-
teinuria. For example, hydrogen peroxide infused directly
into the renal artery causes massive transient proteinuria.
Infusion of myeloperoxidase (MPO) followed by hydro-
gen peroxide in a chloride-containing solution in rats re-
sults in significant proteinuria, followed in four to 10 days
by the development of a marked proliferative glomerular
lesion.
Glomerular filtration rate
The effects of oxidants that potentially contribute to
altered GFR are summarized in Table 1. Oxidants re-
duce the glomerular and mesangial cell planar surface
and increase myosin light chain phosphorylation, a bio-
chemical marker of contraction. These effects could mod-
ulate the surface area of mesangial cells, thus modifying
ultrafiltration coefficient and leading to a decrease in
the GFR. In addition, oxidants increase the synthesis
of prostaglandins and thromboxane, which have been
implicated as important mediators causing proteinuria
and/or a fall in the GFR in various experimental models
of glomerular disease.
Morphologic changes
Several recent studies suggest that oxidants exhibit
several effects that may contribute to the morphologic
changes observed in a variety of glomerular diseases
(Table 1). Necrotizing crescentic glomerulonephritis as-
Table 1. Biologic effects of oxidants relevant to chronic kidney
disease [2, 4, 34]
Relevant to the occurrence of proteinuria
ROM participate in GBM degradation
Lipid peroxide induces enhanced generation of gelatinase by
mesangial cells
ROM decrease de novo synthesis of glomerular proteoglycans
ROM increases albumin permeability in freshly isolated glomeruli
in vitro
Infusion of phorbol myristate acetate, an activator of neutrophils,
results in proteinuria and a fall in GFR. These effects are
prevented by catalase
Hydrogen peroxide infused directly into the renal artery causes
massive transient proteinuria by inducing a molecular size-
selectivity defect
Infusion of myeloperoxidase-hydrogen peroxide induces proteinuria
Relevant to altered GFR
Oxidants generated enzymatically or by stimulated neutrophils
Increase glomerular eicosanoid synthesis
Increase glomerular cyclic AMP content
Induce a reduction in glomerular and mesangial cell planar surface
and myosin light chain phosphorylation. These effects appear to
be mediated by PAF
ROM have an effect on release and inactivation of TNF-a
Relevant to morphologic changes
Infusion of myeloperoxidase-hydrogen peroxide causes significant
proteinuria, marked influx of platelets, endothelial cell swelling,
and epithelial cell foot process effacement. Four to 10 days later
a marked proliferative glomerular lesion develops
Scavengers of ROM prevent the reduction in glomerular ADPase
activity and increase in platelet aggregation in anti-Thy 1 and
anti-GBM antibody disease models
Rats immunized with myeloperoxidase and perfused with lysosomal
enzyme extract and hydrogen peroxide develop a proliferative
glomerulonephritis
sociated with anti-MPO antibodies are part of antineu-
trophil cytoplasmic autoantibodies (ANCA)-associated
glomerulonephritis. It is characterized by segmental fib-
rinoid necrosis of the GBM, marked infiltration of neu-
trophils, and mononuclear cells. Similar morphologic
changes have been described in rats immunized with
MPO and perfused with lysosomal enzyme extract and
hydrogen peroxide.
A number of monocyte-specific cytokines have been
described and include the monocyte colony-stimulating
factor (CSF-1) and the monocyte chemoattractant pro-
tein (MCP-1). Generation of reactive oxygen species,
possibly by NADPH-dependent oxidase, is involved in
the induction of the MCP-1 genes by tumor necrosis
factor-a (TNF-a) and immunoglobulin G (IgG) com-
plexes in mesangial cells. Local generation of oxidants
could represent a factor responsible for the expression
of MCP-1 in immune-mediated increased expression of
monocyte chemoattractant protein in glomeruli from rats
with anti-Thy-1 glomerulonephritis, and in other mod-
els where monocyte infiltration is a prominent feature of
glomerular disease. Both in vitro and in vivo studies in-
dicate that oxidants are capable of inducing many of the
functional and morphologic changes that are observed in
glomerular diseases.
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Table 2. Oxidants in leukocyte-dependent glomerular disease [2, 4,
34]
In vitro studies
A wide variety of soluble and particulate stimuli, including immune
complexes, complement components, and ANCA, enhance
generation of oxidants by leukocytes
In vivo studies
Cytochemical detection of the presence of superoxide- and
hydrogen peroxide–generating leukocytes in anti-GBM- and
anti-Thy-1-induced glomerulonephritis
Enhanced superoxide and hydroxyl radical generated by
macrophages isolated from glomeruli of rabbits with anti-GBM
antibody disease or glomeruli from the anti-Thy-1 model
Induction of nitric oxide synthase in infiltrating leukocytes from
human renal biopsy tissue of proliferative glomerulonephritis and
in the anti-GBM model
Enhanced generation of nitric oxide by glomeruli isolated from the
anti-Thy-1 model
Significant reduction in proteinuria by catalase, a hydroxyl radical
scavenger, and an iron chelator in complement- and
neutrophil-dependent heterologous phase of anti-GBM antibody
disease
ROLE OF OXIDANTS IN
LEUKOCYTE-DEPENDENT
GLOMERULONEPHRITIS
Several studies strongly support the role of leukocytes
in reducing glomerular injury that results in protein-
uria (Table 2). A wide variety of soluble and particulate
stimuli that appears to be relevant to the pathophysiol-
ogy of glomerulonephritis can activate neutrophils and
monocytes to release enormous amounts of oxidants.
Thus, stimulated neutrophils or monocytes are potential
sources of oxidants in leukocyte-dependent glomerular
injury.
Anti-GBM antibody disease
One of the best-characterized models of complement-
and neutrophil-dependent glomerular injury is the
heterologous phase of anti-GBM antibody disease. In-
filtrating neutrophils and macrophages generate large
amounts of superoxide anion (hydrogen peroxide) in this
model of glomerulonephritis. Treatment with catalase
markedly reduces the proteinuria, as do dimethylth-
iourea (a potent hydroxyl radical scavenger) and defer-
oxamine. Although the role of iron is not completely
understood, the protective effect of iron chelators gen-
erally has been taken as evidence for the participation of
hydroxyl radical in tissue injury, because iron is critical in
the generation of hydroxyl radical.
ROLE OF OXIDANTS IN
LEUKOCYTE-INDEPENDENT
GLOMERULONEPHRITIS
Puromycin aminonucleoside model of minimal change
disease in humans
A single intravenous injection of puromycin aminonu-
cleoside results in marked proteinuria and glomeru-
lar morphologic changes which are similar to minimal
Table 3. Evidence for the role of oxidants in puromycin
aminonucleoside model of minimal change disease [2, 4, 34]
In vitro, cultured glomerular epithelial cells and glomeruli
have enhanced generation of hydrogen peroxide
Scavengers of oxidants and antioxidants result in reduction in
proteinuria in this model of minimal change
A selenium-deficient diet results in marked diminution of glutathione
peroxidase and an increase in proteinuria
Induction of antioxidant enzymes by glucocorticoids protects against
puromycin aminonucleoside–induced proteinuria
Catalytic iron is increased in glomeruli
Used with permission from Mosby-Year Book, Inc. in Current Nephrology,
Baliga R, Ueda N, Shah SV: Oxidant Mechanisms in Glomerular Disease, vol. 20,
1997, pp 135–151.
change disease in humans. It is clear that oxidants play an
important role in the development of this model (Table 3).
Puromycin aminonucleoside enhances the generation of
superoxide anion, hydrogen peroxide, and hydroxyl radi-
cal when added to freshly isolated glomeruli. Glomerular
epithelial cells have been shown to be the target of injury
in many of the noninflammatory forms of glomerular dis-
ease, including the nephrotic syndrome induced by the
injection of puromycin aminonucleoside. In response to
puromycin aminonucleoside, cultured glomerular epithe-
lial cells have been shown to enhance the generation of
hydrogen peroxide. In vivo evidence for the role of ox-
idants comes from the ability of several different scav-
engers of oxidants to prevent or reduce proteinuria in
this model of glomerular disease. Bleomycin-detectable
iron (iron capable of catalyzing free radical reactions)
was markedly increased in glomeruli from nephrotic rats
when compared to control. Deferoxamine prevented the
increase in bleomycin-detectable iron in glomeruli and
provided complete protection against proteinuria, sug-
gesting an important pathogenic role for glomerular cat-
alytic iron in the puromycin aminonucleoside–induced
minimal change nephrotic syndrome.
There is other supporting evidence for a role for oxi-
dants in puromycin aminonucleoside–induced nephrotic
syndrome (Table 3). Glutathione peroxidase is a seleno
enzyme that catalyzes the reduction of hydrogen perox-
ide to water. Feeding rats a selenium-deficient diet results
in marked diminution of glutathione peroxidase and is ac-
companied by a marked increase in urinary protein fol-
lowing puromycin aminonucleoside injection, suggesting
an important role of glutathione peroxidase in this model
of glomerular disease. Similarly, inhibition of superox-
ide dismutase augments puromycin aminonucleoside-
induced proteinuria. These studies not only demonstrate
the importance of endogenous antioxidant defenses, but
also provide additional support for the role of oxidants
in these models of glomerular injury.
Passive Heymann nephritis model of
membranous nephropathy
Passive Heymann nephritis, induced by a single
intravenous injection of anti-Fx1A, is a complement-
dependent and neutrophil-independent model of
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Table 4. Evidence for the role of oxidants in an animal model of
membranous nephropathy [2, 4, 34]
In the passive Heymann nephritis model of membranous nephropathy
Glomeruli demonstrate the presence of hydrogen peroxide
Hydroxyl radical scavengers and an iron chelator and
probucol-reduced proteinuria
Feeding selenium-deficient diet results in marked diminution of
glutathione peroxidase and worsening of proteinuria
Feeding iron-deficient diet results in a reduction in proteinuria
Table 5. Oxidants in diabetic nephropathy
In vitro studies [5, 8]
Activation of PKC and NK-jB
Up-regulation of TGF-b1
Up-regulation of fibronectin
Up-regulation of endothelin-1
In vivo studies [7, 8, 19]
Increased production of superoxide and hydrogen peroxide
Diabetic nodular lesions in humans stain positive for MDA
glomerular disease that resembles membranous
nephropathy in humans (Table 4). In in vivo stud-
ies, enhanced generation of hydrogen peroxide has
been demonstrated in this model of membranous
nephropathy.
Administration of scavengers of hydroxyl radical or
deferoxamine markedly reduces proteinuria, which sug-
gests a role of the hydroxyl radical in passive Hey-
mann nephritis. Similarly, hydroxyl radical scavengers
significantly reduce proteinuria in the cationized gamma
globulin–induced immune complex glomerulonephritis, a
complement-[dependent?] and neutrophil-independent
model of membranous nephropathy. Glutathione per-
oxidase is also an important defense enzyme in this
model. Rats on a selenium-deficient diet have decreased
glutathione peroxidase activity and a worsening of pro-
teinuria. Malondialdehyde adducts (a marker of lipid per-
oxidation) are localized to the GBM, and type IV collagen
is modified by malondialdehyde adducts. Taken together,
these studies suggest an important role for hydroxyl rad-
ical in animal models of membranous nephropathy.
DIABETIC NEPHROPATHY
There is a large body of evidence indicating that di-
abetes is a state of increased oxidative stress [12–14]. I
will summarize only the information directly pertinent
to diabetic nephropathy. It was reported that a hydroxyl
radical–like species was responsible for the changes in the
arterial wall proteins in a model of diabetes in monkeys
[15]. In an excellent review, Nishikawa and Brownlee ar-
gue and provide convincing evidence that oxidants are
the causative link for all the major pathways that have
been implicated in diabetic complications including acti-
vation of aldose reductase pathway, induction of the di-
acylglycerol pathway, activation of protein kinase C, and
induction of advanced glycation end-products in an arti-
cle entitled, “The missing link: A single unifying mecha-
nism for diabetic complications” [5].
In addition to these effects on the vascular bed [5, 15–
17], which are likely to be important in the glomeru-
lar vascular bed, there is more direct evidence for oxi-
dants in diabetic nephropathy [6–8, 18, 19]. In in vitro
studies, it has been shown that high glucose results in
increased generation of reactive oxygen species by
mesangial cells. Similarly, it has been shown that high glu-
cose results in lipid peroxidation in isolated glomeruli,
which is prevented by hydroxyl radical scavengers [6].
High glucose has also been shown to affect several bio-
logic processes in glomeruli that have been implicated in
diabetic nephropathy, and antioxidants have been shown
to inhibit these processes. For example, antioxidants pre-
vented glucose-induced activation of protein kinase C
(PKC) and nuclear factor-jB (NK-jB) up-regulation of
tumor growth factor-b1 (TGF-b1), up-regulation of fi-
bronectin [7], and up-regulation of endothelin-1 [8]. In in
vivo studies, glomeruli isolated from diabetic rats have in-
creased production of superoxide and hydrogen peroxide
[7, 8], and kidneys from diabetic rats exhibit lipid perox-
ides and 8-OhdG [6]. Diabetic nodular lesions in humans
stained positive for MDA, an index of lipid peroxidation
[19].
Iron content in the kidney has been shown to be in-
creased in an animal model of diabetes [20]. It has been
shown that the urinary iron excretion is increased early
in the course of diabetic renal disease in humans [21].
Howard et al demonstrated that diabetic patients with
microalbuminuria and overt proteinuria have a marked
increase in urinary iron.
ROLE OF OXIDANTS AND IRON IN
PROGRESSIVE KIDNEY DISEASE
Although there is evidence for both oxidants and iron
in progressive renal disease, in this section we emphasize
the role of iron because of the possibility of using iron
chelators in preventing progression. The data supporting
the role of iron in models of progressive renal disease con-
sists of demonstration of increased iron in the kidney in
these models of progressive kidney disease; enhanced ox-
idant generation, which provides a mechanism by which
iron can be mobilized; and, more directly, the beneficial
effect of iron-deficient diets and iron chelators. Rats with
proteinuria have increased iron content in proximal tubu-
lar cells, and iron accumulation was the only independent
predictor of both functional and structural damage [22].
Similarly, it has been shown there is a substantial iron
accumulation associated with increased cortical malon-
dialdehyde in proximal tubular cells in the remnant kid-
ney, suggesting reactive oxygen species generation. Iron
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accumulation has also been studied in human chronic re-
nal disease [23].
The sources of increased iron in the kidney have not
been well delineated, but Alfey et al have suggested that
urinary transferrin provides a potential source of iron.
Glomerular injury of any type impairs glomerular perms-
electivity, thereby leading to the leakage of proteins, in-
cluding transferrin, into the urinary space.
At a pH below 6.5, iron has been shown to dissoci-
ate from transferrin in urine. As pH decreases as urine
courses along the nephron, iron is released from trans-
ferrin [24, 25], thus providing a source of iron that could
act on renal tubular epithelial cells or be absorbed into
the tubules. Information about other potential sources,
including intracellular sources of iron in the kidney, is
available for only acute models of renal injury. Thus, mi-
tochondria have been suggested as sources of iron in gen-
tamicin nephrotoxicity, whereas cytochrome C has been
shown to be an important source of catalytic iron in is-
chemic and toxic injury [26].
For iron to be important in causing renal injury, it is also
important to demonstrate increased generation of oxi-
dants. The oxidants would then play a role in mobilizing
iron, as well as interacting with the mobilized iron to gen-
erate highly reactive metabolites. Nath et al have carried
out a series of studies that have provided compelling evi-
dence for a role for oxidants in progressive renal disease
[27, 28]. Increased rates of oxygen consumption, which
occur in surviving nephrons, is linked to ammoniagene-
sis and increased generation of reactive oxygen species,
both of which have been incriminated in progressive re-
nal injury [27]. It has been shown also that diets deficient
in selenium and vitamin E weanling rats enhances am-
moniagenesis, compromises renal function in the intact
kidney, and induces tubulointerstitial injury [29].
Several studies have examined the effect of iron-
deficient diet or iron chelators on progression of chronic
kidney disease. Alfrey et al have shown a marked effect
of iron-deficient diet or an iron chelator on preventing
the development of tubulointerstitial disease and renal
functional deterioration in nephrotoxic serum nephritis
[24, 30]. Remuzzi et al have shown that rats fed an iron-
deficient diet had significant reduction in proteinuria, and
developed less glomerulosclerosis [31]. Iron chelator sig-
nificantly reduced iron accumulation and tubular damage
[32] in rat remnant kidneys (a model for progressive renal
disease).
The precise cellular mechanisms by which oxidants and
iron participate in progression are not known. However,
oxidants and iron have many cellular effects that are po-
tentially important in tubulointerstial damage, fibrosis,
and matrix accumulation. For example, it is well estab-
lished that oxidants and iron play an important role in
cellular injury and cell death, including apoptosis. Thus,
conceivably they could play a role in tubular atrophy and
loss of cells, which is a common feature of progressive
renal disease. In addition, lipid peroxidation has been
shown to be important in induction of collagen gene ex-
pression [33], and may thus contribute to renal fibrosis.
CONCLUSION
A sufficient body of in vitro and in vivo information
exists to postulate that oxidants appear to be important
mediators in glomerular pathophysiology and in progres-
sive kidney disease. Nonetheless, the multifaceted nature
of tissue injury makes it almost a certainty that the co-
operative and sometimes complex interactions between
different injurious mechanisms are important in the final
expression of injury.
While the collective information on the role of oxi-
dants and iron derived both from models of glomerular
disease, as well as progressive renal failure, is impressive,
there is virtually no information on the potential role of
these mechanisms in human disease. There are many dif-
ferences between animal models of glomerular disease
and glomerular disease in humans. For example, the an-
imal model of minimal change disease is a toxic model,
whereas the mechanism of minimal change disease in hu-
mans is not known. Similarly, the anti-Fx1A antibody that
is used for the animal model of membranous nephropathy
has been difficult to demonstrate in human membranous
nephropathy.
Indeed, the lessons from animal models of acute re-
nal failure have been disappointing when attempting to
translate to human disease. In the future, control studies
in a large number of patients will be required to demon-
strate the efficacy of antioxidants and/or iron chelators
in retarding progression of renal failure, and may offer
important therapeutic modality to patients with chronic
kidney disease.
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